Lecture 13 Flashcards

(53 cards)

1
Q

antenatal care

A
regular midwife visits 
check SFH plotted on GROW chart
foetal movements discussed 
BP 
urine dipstick for proteinurea 
GTT 
diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

placental dysfunction

A

small
abnormal
impaired function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

inability to support foetal growth

A

FGR

pre-eclampsia (PE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FGR + PE

A

increasing foetal demand with gestation leading to a still birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

FGR

A

failure to reach genetic growth potential

5-6% of pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

consequences of FGR

A

latrogenic preterm birth
neonatal death
life long disabilities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

developmental programming in FGR

A
obesity
FGR
metabolic syndromes 
diabetes 
schizophrenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

still births

A

1:220
age increases risk
smoking
chronic hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

placental abnormalities in FGR

A

size and structure
functional abnormalities
could be due to incest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

size and structure

placental abnormalities in FGR

A

villous and vascular tree in placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

functional abnormalities

placental abnormalities in FGR

A

nutrient transport
cell turnover
endocrine function
vascular funciton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

macroscopic placenta

A

small

infarcts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

microscopic placenta

A
decreased branching of villous tree 
fewer and smaller terminal villi 
reduced surface area 
thicker SYNC 
slower diffusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

placental vascularisation

A

decrease in FGR of placental villi

can effect flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

increase in placental vascularisation resistance in FGR

A

placental arteries constrict more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nutrient transport in FGR

A

reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

placental hormones in FGR

A

reduced

hPL, PGH, PIGF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

maternal vascular malperfusion

A

maternal blood delivered to foetus via spiral uterine arteries

high volume blood flow to placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

transformation of maternal vascular malperfusion during early pregnancy

A

EVT - extravillous trophoblast

enlarged sinus
high volume
low resistance blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PE symptoms

A

hypertension
proteinurea
oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PE associated with

A

FGR

multisystem disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PE treatment

23
Q

PE characterised by

A

higher resistance in maternal arteries

adherent spiral arteries remodelling

uteroplacental function reduced

placental damage due to shear force from high pressure blood flow

oxidative stress

micro-particles activating immune and vascular endothelial

24
Q

vascular endothelium inappropriately activated

A
oedema
vasoconstriction
proteinurea
cerebral artery spasms 
platelet activation 
clumping
25
factors released by PE placenta
reduces ATP in maternal vascular endothelial
26
why can you not investigate PE
uterine artery doppler is not abnormal
27
transcriptonomics and PE
330 PE human placentas microarray bioinformatics mRNA showed common levels
28
causes of PE according to bioinformatics
immunological canorial maternal chromosome abnormalities
29
placental screening for second trimester
``` high risk women screened look at serum biomarkers fetal biometry umbilical and uterine artery doppler placental size and morphology ```
30
doppler looks at
iliac artery via ultrasound
31
doppler FGR and PE
reduced blood flow (EDF) increased resistance diastolic notching
32
doppler in maternal vascular malperfusion
reduced oxygen and nutrient supply
33
placental morphology
size - depth, length, diameter texture cord insertion
34
fetal biometry and EFW
head circumference abdominal circumference femur length umbilical artery doppler
35
pre term delivery
single biggest cause of neonatal deaths risk of mortality if inversely proportional to gestation age at birth 75% PPROM, PTL
36
pre-term delivery causes
unknown | infections
37
risk factors of pre-term delivery
previous PTB | cervical trauma
38
prior history of pre-term birth | MEDICAL
prophylactic vaginal progesterone | prophylactic cervical cercalge
39
prior history of pre-term birth | MECHANICAL
prophylactic vaginal progesterone prophylactic cervical cercalge stitching is required
40
PTL medication
tocolytics - nifidapiene atosbian indomethacin
41
tocolytics - nifidapiene
relax uterine muscle | ca2+ channel blocker
42
atosbian
oxytocin receptor antagonist
43
indomethacin
COX inhibitor | stops PG synthesis
44
mouse model advantages
``` ease of genetic manipulation can study KO on foetus and placenta expresses GLUT1, Ca2+ ATPases and system A cheap short gestation both have hemochorial placentas ```
45
mouse model disadvantages
short gestation different to humans large litters difference in placental structures
46
placental structures in mice and humans
``` decidua (maternal) invasive trophoblast placenta chorionic plate umbilical cord ```
47
human difference
villous placenta one main structure hemoMONOchorical invasive trophoblast
48
mouse differences
labyrinthine 2 main zones hemoTRIchorical invasive trophoblast
49
available mouse models
placental specific Igf2 KO
50
PO Igf2 KO
KO in placenta and normal everywhere else FGR and placental growth restriction 50% decrease in labyrinthine surface area
51
IGF2
key placental growth factor
52
IGF2 KO
reduced passive permeability | structural abnormalities
53
IGF2 KO system A
not reduced increases at E16 placenta tries to overcome small foetal size